Report cover image

Markets for Blood Testing and Typing

Published Jun 09, 2017
Length 210 Pages
SKU # KLI15378333

Description

The Market for Blood Testing and Typing

This Kalorama Information report, Blood Testing and Typing Post-Zika details sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for 2011 to 2016 and forecasts are provided through 2021 and 2026. Historical information was gathered from a wide variety of published sources including company reports, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives were conducted to capture the perspectives from industry participants’ point of view and assess trends.

Excluded from this report are blood testing products used in biopharmaceutical processing/manufacturing/research, and veterinary tests. Also excluded are blood products for transfusion such as red blood cells (RBCs), immunoglobulin products, synthetic blood/albumin, etc. as well as blood testing services/laboratories.

The total global market for blood testing and typing products includes products and devices used in blood banking/donations as well as products used otherwise. This can also be thought of as testing and typing on pooled blood donations (blood bank) versus individual blood samples. In both of these segments, the following products are used:
  • Pathogen screening by immunoassay;
  • Pathogen screening by NAT;
  • Blood typing and grouping;
The global blood industry represents a diverse assortment of companies, groups and organizations that provide for the safe collection, testing, storage and delivery of human blood and blood products for transfusion. These blood transfusions are of critical importance to those with both acute and chronic medical conditions in which blood is depleted or non-functioning, since more than 9 million Americans and Europeans would die each year without transfusions.

The following sections provide highlights of the blood industry’s ongoing technological development and a background on the physiological aspects of human blood, which will form the basis for understanding the blood testing and typing industries profiled in detail in this report’s later chapters.This Kalorama Information report, Blood Testing and Typing Post-Zika details sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for 2011 to 2016 and forecasts are provided through 2021 and 2026. Historical information was gathered from a wide variety of published sources including company reports, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives were conducted to capture the perspectives from industry participants’ point of view and assess trends.

Excluded from this report are blood testing products used in biopharmaceutical processing/manufacturing/research, and veterinary tests. Also excluded are blood products for transfusion such as red blood cells (RBCs), immunoglobulin products, synthetic blood/albumin, etc. as well as blood testing services/laboratories.

The total global market for blood testing and typing products includes products and devices used in blood banking/donations as well as products used otherwise. This can also be thought of as testing and typing on pooled blood donations (blood bank) versus individual blood samples. In both of these segments, the following products are used:
  • Pathogen screening by immunoassay;
  • Pathogen screening by NAT;
  • Blood typing and grouping;
The global blood industry represents a diverse assortment of companies, groups and organizations that provide for the safe collection, testing, storage and delivery of human blood and blood products for transfusion. These blood transfusions are of critical importance to those with both acute and chronic medical conditions in which blood is depleted or non-functioning, since more than 9 million Americans and Europeans would die each year without transfusions.

The following sections provide highlights of the blood industry’s ongoing technological development and a background on the physiological aspects of human blood, which will form the basis for understanding the blood testing and typing industries profiled in detail in this report’s later chapters.

Table of Contents

210 Pages
    • The Global Blood Testing and Typing Industry Post Zika
    • Scope and Methodology
    • The Total Blood Testing and Typing Products Market
    • Overview
    • Zika Virus
    • Effects of the Economy
    • Changes from Health Care Reform
    • Demographic Shifts
    • Basics - Blood and its Components
    • Blood Collection
    • Organizations Collecting Blood
    • Methods for Collecting Blood from Donors
    • Blood Typing and Testing for Diseases
    • Blood Typing
    • Methods of Blood Typing
    • Manual Blood Typing Methods
    • Automated Blood Typing and Screening Methods
    • Molecular methods
    • Reducing Blood Typing Errors
    • Blood Testing
    • Nucleic Acid Amplification Testing (NAT)
    • CBER Licensed NAT Screening Tests
    • Infectious Disease
    • West Nile Virus
    • Oncology
    • Inherited Disease
    • Other
    • Polymerase Chain Reaction (PCR) Amplification
    • CBER Licensed PCR Screening Tests
    • DNA Sequencing/Genetic Testing
    • Immunoassay
    • Infectious Diseases
    • Chagas Disease
    • Cardiac Markers
    • Tumor Markers
    • Diabetes
    • Autoimmune Diseases
    • Other
    • Enzyme-Linked Immunosorbent Assay
    • Basic ELISA
    • Competitive ELISA
    • Reverse Sandwich Method
    • Reverse Sandwich Inhibition Method
    • MAC-ELISA
    • Zika MAC-ELISA
    • Plaque Reduction Neutralization Test (PRNT)
    • Tests for Infectious Disease
    • Improving Viral Screening
    • Costs and Other Barriers
    • Testing Before Transfusion
    • Coombs Test
    • Crossmatch
    • Major Crossmatch
    • Minor Crossmatch
    • Antibody Screen
    • Efforts to Create a Virus-Free Blood Supply
    • Plasma Treatment
    • Platelet Treatments
    • Testing for Contamination
    • Pathogen Reduction
    • Preventing Bacterial Infections
    • Red Blood Cell Treatments
    • The Total Blood Testing and Typing Products Market
    • Blood Testing Market
    • Blood Typing & Grouping Market and Forecast
    • Competitive Analysis
    • AABB
    • Abbott Laboratories
    • Akers Biosciences
    • America's Blood Centers
    • American Red Cross
    • Beckman Coulter
    • Becton Dickinson & Co.
    • Biomerieux, Inc.
    • Bio-Rad Laboratories
    • DiaSorin
    • Grifols Biologicals, Inc.
    • Hologic
    • Haemonetics
    • Immucor
    • Micronics
    • Ortho Clinical Diagnostics
    • Qiagen Diagnostics
    • Reliance Life Sciences
    • Roche
    • Siemens
    • TerumoBCT
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.